<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04770701</url>
  </required_header>
  <id_info>
    <org_study_id>HIV / AIDS</org_study_id>
    <nct_id>NCT04770701</nct_id>
  </id_info>
  <brief_title>Protect and Improve Cluster of Differentiation 4 (CD4) Cells and B Cells Lymphocytes</brief_title>
  <official_title>Extracts of Plants Eclipta Prostrata, Dioscorea Cirrhosa, Phyllanthus Urinaria, Adenosma Glutinosum, Impatiens Balsamina and Ascorbic Acid Use for in Protecting and Increasing CD4+ T Lymphocytes; B Lymphocytes Level in HIV/AIDS Patients.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Trieu, Nguyen Thi, M.D.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Trieu, Nguyen Thi, M.D.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a plant-based medication used to increase the amount, protect, and reduce HIV's&#xD;
      impact on T and B lymphocytes.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Dioscorea cirrhosa, impatiens balsamina, eclipta prostrata, phyllanthus urinaria, adenosma&#xD;
      glutinosum, and ascorbic acid are used to elevate T and B lymphocytes level, protect their&#xD;
      cells membrane, decrease the damage of HIV on CD4+ T.&#xD;
&#xD;
      In detail, Diosgenin presented in dioscorea cirrhosa is a precursor of cortisol. Dioscorea&#xD;
      cirrhosa when combined with ascorbic acid helps to balance cortisol levels which reduces cell&#xD;
      inflammation. Flavonoids of dioscorea cirrhosa also help to increase CD4+ T levels.&#xD;
&#xD;
      impatiens balsamina can be used as an antitoxin alternative against bacteria or viruses.&#xD;
      Flavonoids in impatiens balsamina, such as kaempferol, quercetin, rutin, astragalin, have the&#xD;
      ability to reduce the virus's impact on T lymphocyte, protect their cell membrane, produce&#xD;
      antihistamine, protect the cell from inflammation.&#xD;
&#xD;
      Targeted flavonoids in eclipta prostrata, phyllanthus urinaria, adenosma glutinosum are used&#xD;
      to cell repair, protect and increase CD4+ T production.&#xD;
&#xD;
      Ascorbic acid in combination with herbal extracts creates a favorable environment for body&#xD;
      metabolism, improves the medication's effectiveness.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 2015</start_date>
  <completion_date type="Actual">January 10, 2021</completion_date>
  <primary_completion_date type="Actual">January 8, 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>60 people were recruited HIV / AIDS positive between the ages of 20 and 60 and divided into 2 groups according to a random distribution.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>The group of HIV / AIDS uses drugs under study. The group of HIV / AIDS uses a placebo.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>The CD4 cell count measurement</measure>
    <time_frame>- 9 months</time_frame>
    <description>HIV is a fatal infection, characterized by the targeting and destruction of CD4 T lymphocytes in the peripheral blood.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>HIV-1-infection</condition>
  <condition>AIDS</condition>
  <arm_group>
    <arm_group_label>Ahah drug</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants have a decline in CD4 + T-lymphocytes is the hallmark of the human immunodeficiency virus (HIV)-1 infection.&#xD;
Characterized by rapid loss of resistance: AIDS&#xD;
Dermatitis, mouth ulcers, skin rash, itching, weight loss&#xD;
Hepatitis C virus (HCV) (+), Hepatitis B virus (HBV) (+), Tuberculosis (+)&#xD;
Ahah composition contains the following ingredients (concentrated extracts of plants):&#xD;
Eclipta prostrata 200mg, dioscorea cirrhosa 200mg, phyllanthus urinaria 150mg, adenosma glutinosum 150mg, impatiens balsamina 75mg and ascorbic acid 250mg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ahah Placebo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants have a decline in CD4 + T-lymphocytes is the hallmark of the human immunodeficiency virus (HIV)-1 infection.&#xD;
Characterized by rapid loss of resistance: AIDS&#xD;
Dermatitis, mouth ulcers, skin rash, itching, weight loss&#xD;
Hepatitis C virus (HCV)(+), Hepatitis B virus (HBV)(+), Tuberculosis (+)&#xD;
Ahah composition placebo (Ahah not containing concentrated extracts of plants Eclipta prostrata 200mg, dioscorea cirrhosa 200mg, phyllanthus urinaria 150mg, adenosma glutinosum 150mg, impatiens balsamina 75mg and ascorbic acid 250mg)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ahah Drug</intervention_name>
    <description>- Composition Ahah containing concentrated extracts of plants: Eclipta prostrata 200mg, dioscorea cirrhosa 200mg, phyllanthus urinaria 150mg, adenosma glutinosum 150mg, impatiens balsamina 75mg and ascorbic acid 250mg&#xD;
-Take 1tablet x 2 times / 24 hours. Maintained for 9 months.</description>
    <arm_group_label>Ahah drug</arm_group_label>
    <other_name>Ahah</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ahah Placebo</intervention_name>
    <description>- Composition Ahah (not containing concentrated extracts of plants): Eclipta prostrata 200mg, dioscorea cirrhosa 200mg, phyllanthus urinaria 150mg, adenosma glutinosum 150mg, impatiens balsamina 75mg and ascorbic acid 250mg)&#xD;
-Take 1tablet x 2 times / 24 hours. Maintained for 9 months.</description>
    <arm_group_label>Ahah Placebo</arm_group_label>
    <other_name>Ahah</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Participants have a decline in CD4 + T-lymphocytes is the hallmark of HIV-1 infection.&#xD;
&#xD;
        Characterized by rapid loss of resistance: AIDS&#xD;
&#xD;
          -  Dermatitis, mouth ulcers, skin rash, itching, weight loss&#xD;
&#xD;
          -  HCV (+), HBV (+), Tuberculosis (+)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Cancer under all form&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tran Minh Duc, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Trieu, Nguyen Thi, M.D.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Saigon Biopharma Company Limited</name>
      <address>
        <city>Ho Chi Minh City</city>
        <zip>700000</zip>
        <country>Vietnam</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Vietnam</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>January 3, 2021</study_first_submitted>
  <study_first_submitted_qc>February 24, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 25, 2021</study_first_posted>
  <last_update_submitted>February 24, 2021</last_update_submitted>
  <last_update_submitted_qc>February 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

